• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Mercaptor Announces Epilepsy Preclinical Program americanpharmaceuticalreview
    January 13, 2020
    Mercaptor Discoveries announced the advancement of its preclinical program in epilepsy. The program culminates in human trials, beginning in early 2022. Their primary candidate has demonstrated reproducible POC and efficacy in animal seizure models.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service